Document Classification

Section Type: RESULTS

Text: After 4-month treatment and 6-month follow-up there were differences between the trial group and the control group in frequency of acute exacerbation (FAS : P = 0. 013 ; PPS : P = 0. 046) ; duration of acute exacerbation (FAS : P = 0. 005 ; PPS : P = 0. 006) ; scores of physiological, psychological and environment aspects of the WHOQOL-BREF questionnaire (FAS : P = 0. 002, P = 0. 006, P = 0. 000 ; PPS : P = 0. 00, P = 0. 001, P = 0. 000) ; scores of daily living ability, social activity, depression symptoms aspects of the COPD-QOL questionnaire (FAS : P = 0. 000, P = 0. 000, P = 0. 006 ; PPS : P = 0. 002, P = 0. 001, P = 0. 001).